• Profile
Close

Clinical and cost-effectiveness of the Managing Agitation and Raising Quality of Life (MARQUE) intervention for agitation in people with dementia in care homes: A single-blind, cluster-randomised controlled trial

The Lancet Psychiatry Mar 27, 2019

Livingston G, et al. - In view of distressing and costly agitation symptoms among many people with dementia living in care homes, researchers developed and piloted a manual-based intervention (Managing Agitation and Raising Quality of Life in dementia; MARQUE) comprising six sessions, delivered by supervised non-clinical psychology graduates. In this trial, they examined how the MARQUE intervention influenced agitation in residents with dementia after 8 months compared with treatment as usual (TAU). Ten care homes (189 residents) were randomized to the MARQUE intervention and ten care homes (215 residents) to TAU between June 14, 2016, and July 4, 2017. Findings do not support the efficacy of the MARQUE intervention for agitation despite its feasibility and cost-effectiveness in terms of quality of life. Delivery by a professional staff of more intensive intervention, implementing social and activity times, and a longer time to implement change, might be required to address agitation in care homes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay